Share This Article:

The Endocannabinoid, 2-Arachidonoyl Glycerol, Induces Growth Cone Collapse and Neurite Retraction in Growing Peripheral Sensory Neurons

DOI: 10.4236/wjns.2015.51001    2,571 Downloads   2,954 Views  

ABSTRACT

Cannabis has a detrimental impact on the developing nervous system. Therefore, regular consumption of cannabis by pregnant and lactating woman poses a potential risk to neuronal growth in fetuses and infants. Indeed, endogenous cannabis-like molecules called endocannabinoids regulate many physiological processes, including neurogenesis, axon guidance, and synaptic plasticity through CB1 receptors. To investigate the physiological role of CB1 receptors on peripheral sensory nerve growth, the endocannabinoid 2-arachidonoyl glycerol was added to cultured chick dorsal root ganglion neurons. This compound inhibited neurite elongation and induced growth cone collapse in a dose- and time-dependent manner. These data suggest that caution should be exercised regarding maternal cannabis use during pregnancy. Because ectopic sprouting and abnormal neuronal network connections are considered to be a cause of neuropathic pain, our current data imply an additional role of endocannabinoids as inhibitors of the formation of pain-maintenance networks.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Aso, C. , Takazawa, T. , Horiuchi, T. and Saito, S. (2015) The Endocannabinoid, 2-Arachidonoyl Glycerol, Induces Growth Cone Collapse and Neurite Retraction in Growing Peripheral Sensory Neurons. World Journal of Neuroscience, 5, 1-6. doi: 10.4236/wjns.2015.51001.

References

[1] Campolongo, P., Trezza, V., Ratano, P., Palmery, M. and Cuomo, V. (2011) Developmental Consequences of Perinatal Cannabis Exposure: Behavioral and Neuroendocrine Effects in Adult Rodents. Psychopharmacology, 214, 5-15. http://dx.doi.org/10.1007/s00213-010-1892-x
[2] Nutt, D.J., King, L.A. and Phillips, L.D. (2010) Drug Harms in the UK: A Multicriteria Decision Analysis. Lancet, 376, 1558-1565. http://dx.doi.org/10.1016/S0140-6736(10)61462-6
[3] Hutchings, D.E., Martin, B.R., Gamagaris, Z., Miller, N. and Fico, T. (1989) Plasma Concentrations of Delta-9-Tetrahydrocannabinol in Dams and Fetuses Following Acute or Multiple Prenatal Dosing in Rats. Life Sciences, 44, 697-701. http://dx.doi.org/10.1016/0024-3205(89)90380-9
[4] Perez-Reyes, M. and Wall, M.E. (1982) Presence of Delta-9-Tetrahydrocannabinol in Human Milk. The New England Journal of Medicine, 307, 819-820. http://dx.doi.org/10.1056/NEJM198209233071311
[5] Jaques, S.C., Kingsbury, A., Henshcke, P., Chomchai, C., Clews, S., Falconer, J., Abdel-Latif, M.E., Feller, J.M. and Oei, J.L. (2014) Cannabis, the Pregnant Woman and Her Child: Weeding out the Myths. Journal of Perinatology, 34, 417-424. http://dx.doi.org/10.1038/jp.2013.180
[6] Berghuis, P., Rajnicek, A.M., Morozov, Y.M., Ross, R.A., Mulder, J., Urban, G.M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., et al. (2007) Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity. Science, 316, 1212-1216. http://dx.doi.org/10.1126/science.1137406
[7] Aguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., Lutz, B., Guzman, M. and Galve-Roperh, I. (2007) The CB1 Cannabinoid Receptor Mediates Excitotoxicity-Induced Neural Progenitor Proliferation and Neurogenesis. Journal of Biological Chemistry, 282, 23892-23898.
http://dx.doi.org/10.1074/jbc.M700678200
[8] Harkany, T., Guzman, M., Galve-Roperh, I., Berghuis, P., Devi, L.A. and Mackie, K. (2007) The Emerging Functions of Endocannabinoid Signaling during CNS Development. Trends in Pharmacological Sciences, 28, 83-92. http://dx.doi.org/10.1016/j.tips.2006.12.004
[9] Bridges, D., Rice, A.S., Egertova, M., Elphick, M.R., Winter, J. and Michael, G.J. (2003) Localisation of Cannabinoid Receptor 1 in Rat Dorsal Root Ganglion Using in Situ Hybridisation and Immunohistochemistry. Neuroscience, 119, 803-812.
http://dx.doi.org/10.1016/S0306-4522(03)00200-8
[10] Ahluwalia, J., Urban, L., Capogna, M., Bevan, S. and Nagy, I. (2000) Cannabinoid 1 Receptors Are Expressed in Nociceptive Primary Sensory Neurons. Neuroscience, 100, 685-688.
http://dx.doi.org/10.1016/S0306-4522(00)00389-4
[11] Amaya, F., Shimosato, G., Kawasaki, Y., Hashimoto, S., Tanaka, Y., Ji, R.R. and Tanaka, M. (2006) Induction of CB1 Cannabinoid Receptor by Inflammation in Primary Afferent Neurons Facilitates Antihyperalgesic Effect of Peripheral CB1 Agonist. Pain, 124, 175-183.
http://dx.doi.org/10.1016/j.pain.2006.04.001
[12] Senba, E. and Kashiba, H. (1996) Sensory Afferent Processing in Multi-Responsive DRG Neurons. Progress in Brain Research, 113, 387-410. http://dx.doi.org/10.1016/S0079-6123(08)61100-0
[13] Bottenstein, J.E., Skaper, S.D., Varon, S.S. and Sato, G.H. (1980) Selective Survival of Neurons from Chick Embryo Sensory Ganglionic Dissociates Utilizing Serum-Free Supplemented Medium. Experimental Cell Research, 125, 183-190. http://dx.doi.org/10.1016/0014-4827(80)90202-5
[14] Radwan, I.A., Saito, S. and Gotom, F. (2002) Growth Cone Collapsing Effect of Lidocaine on DRG Neurons Is Partially Reversed by Several Neurotrophic Factors. Anesthesiology, 97, 630-635. http://dx.doi.org/10.1097/00000542-200209000-00017
[15] Saito, S., Radwan, I., Obata, H., Takahashi, K. and Goto, F. (2001) Direct Neurotoxicity of Tetracaine on Growth Cones and Neurites of Growing Neurons in Vitro. Anesthesiology, 95, 726-733.
http://dx.doi.org/10.1097/00000542-200109000-00027
[16] Seki, T., Abdel Nazeer, A., Sekimoto, K., Guao, Y., Al-Jahdari, W. and Saito, S. (2010) Fibroblast Growth Factor and Insulin-Like Growth Factor Rescue Growth Cones of Sensory Neurites from Collapse after Tetracaine-Induced Injury. Anesthesia and Analgesia, 110, 1468-1472.
http://dx.doi.org/10.1213/ANE.0b013e3181d31ea6
[17] Saito, S. (1997) Effects of Lysophosphatidic Acid on Primary Cultured Chick Neurons. Neuroscience Letters, 229, 73-76.
http://dx.doi.org/10.1016/S0304-3940(97)00397-2
[18] Mitrirattanakul, S., Ramakul, N., Guerrero, A.V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K.F. and Spigelman, I. (2006) Site-Specific Increases in Peripheral Cannabinoid Receptors and Their Endogenous Ligands in a Model of Neuropathic Pain. Pain, 126, 102-114.
http://dx.doi.org/10.1016/j.pain.2006.06.016
[19] Petrosino, S., Palazzo, E., de Novellis, V., Bisogno, T., Rossi, F., Maione, S. and Di Marzo, V. (2007) Changes in Spinal and Supraspinal Endocannabinoid Levels in Neuropathic Rats. Neuropharmacology, 52, 415-422. http://dx.doi.org/10.1016/j.neuropharm.2006.08.011
[20] Ashton, J.C. and Milligan, E.D. (2008) Cannabinoids for the Treatment of Neuropathic Pain: Clinical Evidence. Current Opinion in Investigational Drugs, 9, 65-75.
[21] Martin Fontelles, M.I. and Goicoechea Garcia, C. (2008) Role of Cannabinoids in the Management of Neuropathic Pain. CNS Drugs, 22, 645-653. http://dx.doi.org/10.2165/00023210-200822080-00003
[22] Hosking, R.D. and Zajicek, J.P. (2008) Therapeutic Potential of Cannabis in Pain Medicine. British Journal of Anaesthesia, 101, 59-68. http://dx.doi.org/10.1093/bja/aen119

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.